Foundation for Sarcoidosis Research is ranked #3 of 46 philanthropy & grantmaking organizations in Chicago, IL, with an America's Best Score of 86 out of 100, based on its 2025 Form 990.
Foundation for Sarcoidosis Research is a 501(c)(3) organization, classified under Philanthropy & Grantmaking (NTEE T31). Contributions are tax-deductible.
320 W Ohio St, Chicago, IL 60654-6566
Among the 72 scored philanthropy & grantmaking organizations in Chicago, Foundation for Sarcoidosis Research holds 55.7 months of operating reserves (peer median 12.1 months), runs a typical yearly surplus of 14.7% (peers: surplus of 2.3%), and has grown spending 23.4% a year (peers: grown spending 4.8% a year).
In fiscal year 2025 it reported $4,662,058 in revenue and $3,810,958 in expenses, with contributions making up 85.5% of revenue.
The Foundation for Sarcoidosis Research (fsr) is the leading international organization dedicated to finding a cure for sarcoidosis and improving care for sarcoidosis patients through research, education, and support. Since its establishment in 2000, fsr has fostered over $7.5 million in sarcoidosis specific research efforts.
Largest programs · fiscal year 2025
Fsr research funding - the Foundation for Sarcoidosis Research provided $875,600 in sarcoidosis research funding in 2025. Fsr provided three fellowships in the amount of $150,000 each, two cardiac grants in the amount of $100,000 each, two pilot grants in the amounts of $100,000 and $99,600, and one fsr/American heart association partner grant in the amount of $26,000. Fsr also hosts a patient reg… Read more
Fsr research funding - the Foundation for Sarcoidosis Research provided $875,600 in sarcoidosis research funding in 2025. Fsr provided three fellowships in the amount of $150,000 each, two cardiac grants in the amount of $100,000 each, two pilot grants in the amounts of $100,000 and $99,600, and one fsr/American heart association partner grant in the amount of $26,000. Fsr also hosts a patient registry with nearly 7,500 participants from 68 countries and provides ongoing support to academia and industry in ensuring all clinical trials and research are patient centered.
$1,553,084 spent · 54.2% of program spending
Fsr global sarcoidosis clinic alliance (fsr-gsca) clinical support - comprised of 46 member institutions, the fsr-gsca is a powerful network of institutions that support patients, caregivers, and clinicians, through educational and support programming. The fsr-gsca reaches over 4000 clinicians with clinical education programming from over 40 countries. Through this program, fsr coordinates continu… Read more
Fsr global sarcoidosis clinic alliance (fsr-gsca) clinical support - comprised of 46 member institutions, the fsr-gsca is a powerful network of institutions that support patients, caregivers, and clinicians, through educational and support programming. The fsr-gsca reaches over 4000 clinicians with clinical education programming from over 40 countries. Through this program, fsr coordinates continuing education educational programs for clinicians including the fsr clinical education and engagement series, the fsr journal club, and the fsr case conference program, which provide insights that lead to practice changing behavior by attendees and participants. Fsr is now supporting regional clinical education meetings through program and marketing support to reach beyond experts to the pool of local physicians and advanced practitioners.
$1,096,474 spent · 38.3% of program spending
Fsr patient support and education - fsr provides extensive support to patient and caregivers impacted by sarcoidosis through information & referral services, assistance to financial resources, 1:1 peer to peer patient support program (patient navigators), national virtual support group, and local support groups affiliated with the fsr global sarcoidosis clinic alliance. Fsr hosts webinars, town ha… Read more
Fsr patient support and education - fsr provides extensive support to patient and caregivers impacted by sarcoidosis through information & referral services, assistance to financial resources, 1:1 peer to peer patient support program (patient navigators), national virtual support group, and local support groups affiliated with the fsr global sarcoidosis clinic alliance. Fsr hosts webinars, town halls, podcasts, virtual summits, and in-person educational events to provide patients and family members with education from world-renowned sarcoidosis experts. Fsr works with the nih, fda, and dod to ensure the sarcoidosis is considered in all aspects for federal research and drug development. Fsr is committed to ensuring clinical trials represent all in our community and has been leading efforts to reduce barriers to clinical trial access, including coverage under fmla and paid time off.
$215,975 spent · 7.5% of program spending
Where each dollar went · fiscal year 2025
Of every dollar it spent, 75¢ went to programs, 18¢ to management and 7¢ to fundraising.
Programs $2,865,533
Management $681,883
Fundraising $263,542
In the organization's own words to the IRS, shown for context. None of this affects the America's Best Score, and a Form 990 describes programs without measuring their results.
Spending on programs Not scored; America's Best needs 65%+
75%
Meets
Compared with Chicago peers
Measure
This organization
Peer median
Operating reserves
55.7 mo
12.1 mo
Typical margin
+14.7%
+2.3%
Spending growth
+23.4% / yr
+4.8% / yr
Debt load
5.9%
5.9%
Peers: the 72 Chicago philanthropy & grantmaking organizations with a score, ranked or below the bar.
Tax filings by year
Financial data extracted from the Form 990 the organization filed with the IRS for each fiscal year. Revenue lines can exceed 100% when other items, such as fundraising event costs, are netted against total revenue.
Revenue$4,662,058Fiscal year 2025
Expenses$3,810,958Fiscal year 2025
Total assets$18,793,381Fiscal year 2025
Total liabilities$1,107,498Fiscal year 2025
Fiscal year ending December2025
Revenue$4,662,058
Expenses$3,810,958
Net income$851,100
Net assets$17,685,883
Notable sources of revenue
Percent of total revenue
Contributions
$3,985,033
85.5%
Program services
$97,267
2.1%
Investment income
$717,533
15.4%
Other (net)
−$137,775
−3.0%
Assets / debt
Total assets
$18,793,381
Total liabilities
$1,107,498
Net assets
$17,685,883
Compensation
Not in our extract for this year.
Fiscal year ending December2024
Revenue$13,585,865
Expenses$3,368,016
Net income$10,217,849
Net assets$16,010,727
Notable sources of revenue
Percent of total revenue
Contributions
$13,025,070
95.9%
Program services
$192,325
1.4%
Investment income
$364,032
2.7%
Other (net)
$4,438
0.0%
Assets / debt
Total assets
$17,183,158
Total liabilities
$1,172,431
Net assets
$16,010,727
Compensation
Not in our extract for this year.
Fiscal year ending December2023
Revenue$2,574,104
Expenses$2,402,436
Net income$171,668
Net assets$5,286,996
Notable sources of revenue
Percent of total revenue
Contributions
$2,411,412
93.7%
Program services
$252,937
9.8%
Investment income
$143,978
5.6%
Other (net)
−$234,223
−9.1%
Assets / debt
Total assets
$5,742,895
Total liabilities
$455,899
Net assets
$5,286,996
Compensation
Officers and key employees
$416,000
Share of expenses
17.3%
Fiscal year ending December2022
Revenue$1,673,599
Expenses$2,027,945
Net income−$354,346
Net assets$4,544,998
Notable sources of revenue
Percent of total revenue
Contributions
$1,291,209
77.2%
Program services
$341,425
20.4%
Investment income
$119,287
7.1%
Other (net)
−$78,322
−4.7%
Assets / debt
Total assets
$4,929,854
Total liabilities
$384,856
Net assets
$4,544,998
Compensation
Officers and key employees
$246,000
Share of expenses
12.1%
About this data
Figures come from IRS Form 990 filings, through the IRS Exempt Organizations Business Master File (2026-11-09) and e-filed returns. Form 990 data typically lags 12–24 months behind an organization's fiscal year. Found an error?